http://biz.yahoo.com/ic/news/516.htmlThe latest news on the Diagnostic Substances industry from Yahoo! Financeen-usThu, 3 Jul 2008 15:44:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080703/clth040.html?.v=101Mergent, Inc., administrator for the HealthShares Indexes, a series of 20 underlying indexes for the HealthShares Exchange Traded Funds, today announced the following change effective on the opening of trading on Wednesday July 9, 2008:yahoo_finance/119918569Thu, 3 Jul 2008 15:44:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080703/ukw024.html?.v=56yahoo_finance/1654867936Thu, 3 Jul 2008 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080703/akorn_contract.html?.v=1Specialty pharmaceutical maker Akorn Inc. said Thursday it has signed a five-year commercial manufacturing and supply agreement with Bioniche Pharma.yahoo_finance/1661529505Thu, 3 Jul 2008 11:41:08 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080703/20080703005055.html?.v=1BUFFALO GROVE, Ill.----Akorn, Inc. a specialty pharmaceutical company and Bioniche Pharma have entered into a five-year commercial manufacturing and supply agreement for two undisclosed pharmaceutical products.yahoo_finance/1002836668Thu, 3 Jul 2008 11:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/080702/0412331.htmlyahoo_finance/3112372390Wed, 2 Jul 2008 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12kadp77d/*http://www.marketwatch.com/news/story/drug-stocks-climb-myriad-rebounds/story.aspx?guid=%7BF58C3DFD%2D2BD8%2D4A20%2DA7EB%2D53461C74349E%7D&siteid=yhoofyahoo_finance/3387215516Tue, 1 Jul 2008 20:12:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/080701/13498.html?.v=1yahoo_finance/969224859Tue, 1 Jul 2008 19:31:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080701/neogen_products.html?.v=1Neogen Corp., which makes test kits for food and animal safety, said Tuesday it bought a product line from DuPont Animal Health Solutions for an undisclosed amount.yahoo_finance/4015835138Tue, 1 Jul 2008 19:10:01 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/080701/13491.html?.v=1yahoo_finance/1800206014Tue, 1 Jul 2008 17:23:33 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080701/myriad_genetics_second_look.html?.v=1Shares of Myriad Genetics bounced back Tuesday after a tumble the day before on the biotechnology company's announcement that it will stop development of the Alzheimer's disease treatment Flurizan.yahoo_finance/3199269507Tue, 1 Jul 2008 16:25:52 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/080701/13485.html?.v=1yahoo_finance/1871271533Tue, 1 Jul 2008 16:06:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080701/20080701006016.html?.v=1yahoo_finance/1025081750Tue, 1 Jul 2008 15:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080701/cltu039.html?.v=101Neogen Corporation announced today that it has acquired a product line used in animal health and hygiene applications from DuPont Animal Health Solutions .yahoo_finance/4235786540Tue, 1 Jul 2008 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080701/20080701005137.html?.v=1BELLEVUE, Wash.----SCOLR Pharma, Inc. announced the initiation of the third of three pivotal trials to evaluate the safety and efficacy of its formulation of 12-hour extended-release ibuprofen for the over-the-counter market.yahoo_finance/2990163681Tue, 1 Jul 2008 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080701/netu030.html?.v=59Pressure BioSciences, Inc. today announced that scientists from the New York University School of Medicine and the Brooklyn Hospital Center presented results yesterday on advances they made in the areas of breast and colon cancer, stroke, and in vitro fertilization .yahoo_finance/722630943Tue, 1 Jul 2008 12:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080701/netu027.html?.v=61Palatin Technologies, Inc. today announced that AstraZeneca and Palatin have amended their exclusive global licensing and research collaboration agreement to discover, develop and commercialize compounds that target melanocortin receptors.yahoo_finance/1703443518Tue, 1 Jul 2008 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080701/20080701005484.html?.v=1GAITHERSBURG, Md.----Ore Pharmaceuticals Inc. announced today that it has filed an investigational new drug application with the U.S. Food and Drug Administration for GL1001, the first clinical-stage inhibitor of the ACE2 enzyme.yahoo_finance/621187022Tue, 1 Jul 2008 10:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080701/netu044.html?.v=52Monogram Biosciences, Inc. announced today that William D. Young, CEO and Chairman, is scheduled to present an update on the company's business at the Collins Stewart LLC Fourth Annual Growth Conference on Tuesday, July 8, 2008 at 9:00 a.m. at the Mandarin Oriental Hotel in New York, NY.yahoo_finance/1909459887Tue, 1 Jul 2008 10:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=125l391ed/*http://seekingalpha.com/article/83321-myriad-genetics-i-told-you-so?source=yahooyahoo_finance/3723353637Tue, 1 Jul 2008 08:00:56 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=139cmmh0t/*http://seekingalpha.com/article/83301-amag-s-iron-replacement-therapy-great-potential-problematic-trial?source=yahooyahoo_finance/3414063628Tue, 1 Jul 2008 06:19:37 Etc/GMT